The prothrombotic potential of platelet factor 4

被引:14
作者
Thachil, Jecko [1 ]
机构
[1] Univ Liverpool, Liverpool L7 8XP, Merseyside, England
关键词
Heparin; Monocyte; Platelet; Thrombocytopenia; Thrombosis; HEPARIN-INDUCED THROMBOCYTOPENIA; MONOCYTE TISSUE FACTOR; CARDIOPULMONARY BYPASS; PLATELET FACTOR-4; ENDOTHELIAL-CELLS; ANTIBODIES; ACTIVATION; THROMBOSIS; RELEASE; PREVALENCE;
D O I
10.1016/j.ejim.2009.11.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heparin-induced thrombocytopenia (HIT) is a prothrombotic disorder initiated by heparin administration It is caused by the formation of pathogenic antibodies to complexes of platelet factor-4 (PM) and heparin on platelet surfaces that cause platelet activation, aggregation and thrombosis There has been intense research on this intriguing, drug-related thrombocytopenia explaining several characteristic aspects of this condition However. pi thrombotic potential of the key player, PF4 has not been investigated in many studies although it has been shown to be critical in monocyte chemotaxis, monocyte-platelet interaction, and megakaryocyte suppression. all of which can contribute to the pathophysiology of HIT This article explains the important role of PF4 released during platelet activation with the administration of heparin in the pathogenesis of thrombocytopenia and thrombosis in HIT. (C) 2009 European Federation of Internal Medicine Published by Elsevier B V All rights reserved
引用
收藏
页码:79 / 83
页数:5
相关论文
共 37 条
[1]  
AMELOT AA, 2007, J THROMB HAEMOST S2, P5
[2]   Antibodies from patients with heparin-induced thrombocytopenia stimulate monocytic cells to express tissue factor and secrete interleukin-8 [J].
Arepally, GM ;
Mayer, IM .
BLOOD, 2001, 98 (04) :1252-1254
[3]   Platelet factor 4/heparin antibody (IgG/M/A) in healthy subjects: a literature analysis of commercial immunoassay results [J].
Arepally, Gowthami M. ;
Hursting, Marcie J. .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2008, 26 (01) :55-61
[4]  
Bauer TL, 1997, CIRCULATION, V95, P1242
[5]   PLASMA-LEVELS OF PLATELET FACTOR-4 MEASURED BY RADIOIMMUNOASSAY [J].
CHESTERMAN, CN ;
MCGREADY, JR ;
DOYLE, DJ ;
MORGAN, FJ .
BRITISH JOURNAL OF HAEMATOLOGY, 1978, 40 (03) :489-500
[6]   Heparin-induced thrombocytopenia: An autoimmune disorder regulated through dynamic autoantigen assembly/disassembly [J].
Cines, Douglas B. ;
Rauova, Lubica ;
Arepally, Gowthami ;
Reilly, Michael P. ;
McKenzie, Steven E. ;
Sachais, Bruce S. ;
Poncz, Mortimer .
JOURNAL OF CLINICAL APHERESIS, 2007, 22 (01) :31-36
[7]   PLATELET FACTOR-4 IS CHEMOTACTIC FOR NEUTROPHILS AND MONOCYTES [J].
DEUEL, TF ;
SENIOR, RM ;
CHANG, D ;
GRIFFIN, GL ;
HEINRIKSON, RL ;
KAISER, ET .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (07) :4584-4587
[8]  
EMOFSSON M, 1997, J THORAC CARDIOVASC, V113, P576
[9]   Transgenic mice studies demonstrate a role for platelet factor 4 in thrombosis: dissociation between anticoagulant and antithrombotic effect of heparin [J].
Eslin, DE ;
Zhang, CY ;
Samuels, KJ ;
Rauova, L ;
Zhai, L ;
Niewiarowski, S ;
Cines, DB ;
Poncz, M ;
Kowalska, MA .
BLOOD, 2004, 104 (10) :3173-3180
[10]   Heparin-induced thrombocytopenia is rare in pregnancy [J].
Fausett, MB ;
Vogtlander, M ;
Lee, RM ;
Esplin, MS ;
Branch, DW ;
Rodgers, GM ;
Silver, RM .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2001, 185 (01) :148-152